Synergy between B cell differentiation factors and interleukin 2, using a monoclonal system

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Chronic lymphocytic leukemia (CLL) involves B cell abnormalities.
• B cell differentiation factors (BCDF) regulate B cell maturation.
• Interleukin 2 (IL 2) is a cytokine with known immune functions.

Purpose of the Study:

• To investigate the synergistic effects of IL 2 and BCDF on B cell differentiation.
• To determine the role of the IL 2 receptor (Tac) in this process.
• To explore the potential of IL 2 in modulating B cell maturation.

Main Methods:

• Utilized monoclonal B cell targets and cells from CLL patients.
• Employed BCDF derived from human T cell hybridomas.
• Assessed immunoglobulin secretion and plaque-forming cell (PFC) responses.
• Measured IL 2 receptor (Tac) expression and utilized anti-Tac antibodies for inhibition studies.

Main Results:

• IL 2 significantly augmented B cell differentiation to PFC 10- to 100-fold in the presence of BCDF.
• IL 2 alone did not affect B cell proliferation or immunoglobulin secretion.
• IL 2 induced near-complete Tac expression on B cells, and anti-Tac antibodies inhibited the PFC response.
• IL 2 acted as a secondary or synergistic signal for differentiation, with delayed addition showing no change in PFC response.

Conclusions:

• IL 2 plays a crucial role in B cell maturation.
• The synergistic effect of IL 2 with BCDF enhances immunoglobulin secretion.
• IL 2 mediates its effects on B cell differentiation, in part, through binding to the IL 2 receptor (Tac) on B cells.